Skip to main content
Premium Trial:

Request an Annual Quote

CeMines Relocates from Los Angeles to La Jolla

NEW YORK, June 22 (GenomeWeb News) - CeMines, which is developing its molecular fingerprinting technologies for early-stage diagnostics and therapeutics, has relocated from Los Angeles to an expanded facility in La Jolla, Calif., the company said today.


The new 9,000 square-foot facility in La Jolla, Calif., will enable the company to "build automated analysis systems for high-throughput and high-content screening," and to commercialize products, Roger Attick, president and chief executive officer of CeMines, said in a statement.


The company's research division was formerly located at the Ceders Sinai Medical Center in Los Angeles.


The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.